Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for artificial induction of differentiation of multipotential stem cells into neural precursor cells

A technology of neural precursor cells and pluripotent stem cells, applied in the field of biomedicine, can solve problems such as no cure

Inactive Publication Date: 2017-10-17
ANHUI HUIEN BIOTECH
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to many pathological damages of the nervous system, such as dementia, epilepsy or neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease and other diseases, currently only drugs can be used to prevent the deterioration of the disease, but there is no cure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] S1. Take human embryonic stem cells and inoculate them on BG02 medium, wherein the composition of the culture solution is: 15% KSR, 4ng / mL bFGF, 1.5mmol glutamine, 0.1mol / L β-mercaptoethanol, 1mmol / L non-essential amino acids, 50 μg / mL streptomycin, 50 μg / mL penicillin;

[0021] S2. The medium was placed at 37°C, 5% CO 2 Cultivate in an incubator, replace the culture medium every day, and after the cells are cultured to confluence, add 1mg / ml collagenase IV at 37°C for digestion and passage, inoculate on new feeder cells, the passage ratio is 1:5;

[0022] S3. Transfer the embryonic stem cells cultured in vitro to a four-well culture plate added with neural precursor cell basal medium, and digest them with 0.05% trypsin after 10 days of adherent culture;

[0023] The neural precursor cell basal medium is 50% NeuroBasalMedium, 1% N2 supplement, 1% B27, 1.5 mmol glutamine, 50 μg / mL streptomycin, 50 μg / mL penicillin added to DMEM / F12 medium;

[0024] S4. Inoculate the d...

Embodiment 2

[0026] S1. Human embryonic stem cells were inoculated on BG02 medium, wherein the composition of the culture medium was: 15% KSR, 4ng / mL bFGF, 2mmol glutamine, 0.15mol / Lβ-mercaptoethanol, 1mmol / L L non-essential amino acids, 50 μg / mL streptomycin, 50 μg / mL penicillin;

[0027] S2. The medium was placed at 37°C, 5% CO 2 Cultivate in an incubator, replace the culture medium every day, and after the cells are cultured to confluence, add 1mg / ml collagenase IV at 37°C for digestion and passage, inoculate on new feeder cells, the passage ratio is 1:6;

[0028] S3. Transfer the embryonic stem cells cultured in vitro to a four-well culture plate added with neural precursor cell basal medium, and digest them with 0.05% trypsin after 12 days of adherent culture;

[0029] The basal medium for neural precursor cells is 50% NeuroBasalMedium, 1% N2 supplement, 1% B27, 2 mmol glutamine, 50 μg / mL streptomycin, and 50 μg / mL penicillin added to DMEM / F12 medium;

[0030] S4. Inoculate the dige...

Embodiment 3

[0032] S1. Take human embryonic stem cells and inoculate them on BG02 medium, wherein the composition of the culture medium is: 15% KSR, 4ng / mL bFGF, 1.8mmol glutamine, 0.13mol / L β-mercaptoethanol, 1mmol / L non-essential amino acids, 50 μg / mL streptomycin, 50 μg / mL penicillin;

[0033] S2. The medium was placed at 37°C, 5% CO 2 Cultivate in an incubator, replace the culture medium every day, and after the cells are cultured to confluence, add 1 mg / ml collagenase IV at 37°C for digestion and passage, and inoculate on new feeder cells, the passage ratio is 1:5.5;

[0034] S3. Transfer the embryonic stem cells cultured in vitro to a four-well culture plate added with neural precursor cell basal medium, and digest them with 0.05% trypsin after 11 days of adherent culture;

[0035] The basal medium for neural precursor cells is 50% NeuroBasalMedium, 1% N2 supplement, 1% B27, 1.8 mmol glutamine, 50 μg / mL streptomycin, and 50 μg / mL penicillin added to DMEM / F12 medium;

[0036] S4. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for artificial induction of differentiation of multipotential stem cells into neural precursor cells. The method comprises the following steps: performing in-vitro amplification culture on embryonic stem cells; performing subculture on the embryonic stem cells; and performing induction differentiation and in-vitro amplification on the embryonic stem cells into neural precursor cells. The invention discloses the method for artificial induction of differentiation of the multipotential stem cells into the neural precursor cells, in-vitro culture is implemented in a colony mode, peripheral cells can be relatively easily differentiated since cells in the middle of a colony are dense and the cells have relatively intense mutual action, meanwhile, donor cells used in the method are sufficient in source, high in purity and free of pollution, and thus a novel way is provided for acquiring nerve cells.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular to a method for artificially inducing the differentiation of pluripotent stem cells into neural precursor cells. Background technique [0002] Embryonic stem cells are derived from the inner cell mass of pre-implantation embryos, have self-renewal ability and developmental totipotency, and can differentiate into cell types representing the three germ layers in vivo and in vitro. Thomson established the first human embryonic stem cell line (hES cell ), making embryonic stem cells a big step forward from laboratory research to clinical application. Since then, research on hES cells has made rapid progress. Despite facing many ethical controversies, the application prospect of hES cells in future regenerative medicine is attracting more and more scientists. The in vitro differentiation of hES cells provides a good model for studying the cellular and molecular mechanisms of early embryonic d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/079
CPCC12N5/0618C12N2501/11C12N2501/115C12N2506/02
Inventor 张正亮
Owner ANHUI HUIEN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com